Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has shared an update.
ASKA Pharmaceutical Holdings Co., Ltd. announced a decision to pay dividends of surplus with a record date of March 31, 2025, subject to approval at the upcoming Annual General Meeting. The company plans to increase its annual dividend per share to 55 yen, reflecting a 15 yen increase from the previous fiscal year, aligning with its policy of a 30% consolidated dividend payout ratio. This move underscores ASKA’s commitment to shareholder returns and stable profit distribution.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is committed to returning profits to shareholders and maintaining stable profit distribution.
Average Trading Volume: 47,952
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen61.9B
Learn more about 4886 stock on TipRanks’ Stock Analysis page.